chrisvoncsefalvay/vaers-outcomes huggingface dataset:
TINGLING TONGUE; RED RASH ON NECK, SHOULDERS AND CHEST; MUSCLE ACHES; HEADACHE; PAINS THROUGHOUT THE BODY; CHILLS/SHIVERING; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 14:15 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced pains throughout the body. On 11-APR-2021, the subject experienced chills/shivering. On 11-APR-2021, the subject experienced muscle aches. On 11-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced tingling tongue. On 13-APR-2021, the subject experienced red rash on neck, shoulders and chest. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pains throughout the body, chills/shivering, muscle aches, and headache on 12-APR-2021, and had not recovered from red rash on neck, shoulders and chest, and tingling tongue. This report was non-serious.
Pt recvd HIB vax MAR91-devel Haemophilus Influenza type B meningitis AUG92 ie vax failure;
No additional AE reported; MMR II involved in temperature excursion on 01/01/2021; This spontaneous report was received from a medical assistant referring to a 4 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions and allergies were not provided.     On 01-JAN-2021, measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status recombinant Human albumin (rHA) (M-M-R II) vaccines experienced a temperature excursion at 47.01 Fahrenheit for 1 minute 30 seconds. There was no previous temperature excursion. The temperature excursion was detected by a data logger. On 25-FEB-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (albumin status recombinant Human albumin (rHA) (strength, dose and route were not provided; lot# was S037500 and expiration date was 20-NOV-2021) involved in temperature excursion for prophylaxis (product storage error). No additional adverse event reported.   This is one of the 16 cases received from the same reporter.; Sender's Comments:  US-009507513-2102USA007556: US-009507513-2102USA007557: US-009507513-2102USA007558: US-009507513-2102USA007559: US-009507513-2102USA007568: US-009507513-2102USA007561: US-009507513-2102USA007563: US-009507513-2102USA007564: US-009507513-2102USA005227: US-009507513-2102USA005228: US-009507513-2102USA005229: US-009507513-2102USA005230: US-009507513-2102USA005231: US-009507513-2102USA005232: US-009507513-2102USA003923:
Fatigue, chills, body aches, rash near injection site  Took advil and tylenol (alternating) for chills and body aches  Prescribed Triamcinolone for rash
Information has been received from a physician concerning a 20 year old female with diabetes (unspecified) who on an unspecified date was vaccinated with her second dosage of Gardasil. Since July 2007 the patient has had abdominal and periumbilical pain, possible gastroenteritis since she was given her second dosage of Gardasil. It was reported that the patient sought medical attention and was hospitalized (duration not reported). As of 01-NOV-2007, the patient had not recovered from the events. The patient's abdominal pain and periumbilical pain were considered to be disabling by the reporting physician. Additional information has been requested.
Initial report received from a health care professional on 14 July 2010. Additional information was received on 15 July 2010 via manufacturer telephone call to reporter for clarification of information. A healthy 16-month-old female patient who weighed 7 lbs. 2 oz (3 Kg) at birth, had received a fourth intramuscular left thigh injection of TRIPEDIA (lot number U3282DA) on 08 July 2010. The patient has family history of neurological disorder (not identified). Five days post-vaccination, the patient was taken in the evening to the emergency room for febrile seizure and then sent home. The patient experienced another febrile seizure the following day (14 July 2010) and was taken back to the hospital and admitted for observation. Per the reporter, it was unknown if any relevant diagnostic tests or laboratory data were performed. The patient had no concurrent illnesses at the time of vaccination, no known allergies, or history of medical conditions. She also had not received any other vaccinations within 4 weeks prior to 08 July 2010; and she had not experienced any adverse events with prior vaccinations in the past. At the time of this report, the patient had not recovered. Documents held by sender: None.
1620- Patient began vomiting , sweating, and was warm to touch. Patient denied shortness of breath, tightness in the chest or throat, itching, dizziness, or changes in heart rate. Patient stated, " That she did not eat much today only rice". Pt was given a bottle of water, and crackers, and recieved a mint and was advised to sip the water and eat the crackers slowly.  16:24-Patient ate the crackers, and sipped the water and explained that she was feeling better and is cooling down and the nausea was improving.  She was advised to wait additional 15 minutes for monitoring. 16:34-vitals-BP 106/55, HR-76, O2-97, Temp 99.8. Patient was released from observation at 16:35.
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patents were vaccinated with the improperly stored doses of RECOMBIVAX HB lot #: L040458, expiration date on 04-FEB-2018 (strength, dose number, route and anatomical location were not provided). No adverse events were reported. Administered doses of vaccines experienced the temperature excursion of 31.6 degrees Fahrenheit for 2 hours 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of two reports received from the same source. Additional information has been requested.
4-5 hours after receiving my first dose I started feeling achy and tired. This achiness became worse, I was experiencing cold sweats and developed a low grade fever, 99.9°F.  I slept for 42 hours waking briefly to urinate and drink water.  I was awake for a couple of hours last night and ate. 48 hours later I feel much better, just a few residual achy muscles.
Menstrual cycle was 2 weeks late. My period was much heavier when it did come. And cramping was more than I ever experienced.   I experienced my second period since my first vaccine 28 days after my last period. I did not have the cramping like the previous cycle,  but i  still experienced  heavier than normal period.  Separately, my memory recall seems to be worse post-vaccine.
12/8/2022 in the evening postnasal drip. 12/9 chills, headache, burning in chest, felling like bronchitis developed. 12/10 tested positive at doc via rapid COVID-19 test. Doctor did not prescribe any medication, merely confirmed the test results. Advised of quarantine, and to treat symptomatically. 12/12 contacted PCP who prescribed PAXLOVID. Fever peaked at 102. 12/14 fever broke and symptoms diminished. Just a lingering sinus congestions and occasional cough with fatigue with occasional headache.
Immediate shooting pain, shoulder pain ever since unable to rotate shoulder, lift arm can't sleep from the pain, aspirin, heat, cold, MRI 9/24/2013.
Patient states that several hours after receiving her travel immunizations on 3-11-08 she began to notice ringing in her ears. After 2 weeks she sought medical care. Various tests were run and diagnosis of "tinnitis" was given. She presented herself again in our clinic today to state these facts and to say that the ringing ended this week. She believes the vaccines caused this reaction especially the typhoid vaccine.
09/19/20- VAERS - Patient was given Flucelvax Flu Vaccine around 1:20 pm and experienced tightness in the chest and a generalized weakness a few minutes after administration. Patient was seated in the waiting area and was asked if she wanted an ambulance, and  she declined. Pharmacist kept an eye on her she was able to communicate without any difficulty to the pharmacist. After a approximately 3 minutes pharmacist went to check up on her and she said she wanted us to call an ambulence. She stated she just had tightness in the chest but was able to talk and her physical demeanor did not change. The pharmacist called 911 and an ambulance arrived . Patient was awake, alert, and responsive when paramedics took her to the hospital around 1:35-1:40m. The pharmacist called her at 4:35 pm for a check up call and she was doing well and did not have any problems with tightness in the chest. She stated she did go to the hospital where she was offered treatment with prednisone but the patient stated she declined treatment and was discharged.
Myalgia Fatigue, axillary adenopathy, local arm pain, redness Narrative:
Assessment & Plan:       1. Cellulitis of right arm from Tdap - added to allergies  Start bactrim TODAY  Warm compresses  Change tylenol to 2 aleve BID Elevate as she tolerates  Warm compresses  Off work tomorrow  I marked the erythema to be sure improvement -- would expect in the next 24-48 hours  Close f/u 2 days  To call with NEW/worsening sx in the meantime
Diarrhea; This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (Diarrhea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.
Pt c/o nausea and nasal discharge.  Then developed swelling around face and eyes with development of hives on face.  He then reported difficulty breathing.  Sympoms resolved after administration of Benadryl 50mg PO and Prednisone 20mg PO. EMS called and patient transported to ED in stable condition.
Suddenly, three hours after my vaccine, I had a strong tickle in the back of my throat which caused a lot of coughing. My voice was suddenly hoarse and my chest felt tight and cold. I never had trouble breathing, and it went away suddenly after 3 more hours. I had never experienced anything like this before.
Information has been received from a health professional concerning a 5 year old female pt with no known drug allergies who on 03/20/1997 was vaccinated with a dose of varicella virus vaccine. There was no concominant medications. On 05/16/2001, the pt developed over fifty vesicular lesions and had a 101 deg. fever. There were no other symptoms noted. The reporter considered vaccine failure questionable. The reporter was inquiring about the other cases where children acquired the disease after immunization. The pt sought unspecified medical attention. Additional info has been requested.
This spontaneous retrospective pregnancy report was received from a physician and refers to a newborn patient of unknown gender. The patient's concurrent conditions and concomitant therapies were not reported. On 24-APR-2017, the patient's mother was vaccinated with a dose of VARIVAX subcunateously, lot# M028552 and expiration date 07-JUN-2018 (dose was not reported) for prevention of varicella when she was pregnant. Her gestational age on the date of administration was 13 weeks, 1 day (second trimester), last menstrual period date was estimated on 22-JAN-2017. On an unknown date in 2017, the patient's mother had routine fetal anatomy ultrasounds, all of which were normal. On 06-NOV-2017, at 41 weeks of pregnancy, the patient was born with no complications. It was noted upon delivery that the patient was born with congenital anomaly, an "ear pit" in the right ear. Physician reported that no treatment was necessary for the "ear pit". The outcome of the event was unknown. The relatedness between the event and VARIVAX was not reported. Upon internal review, the "ear pit" was considered to be medically significant event. The mother's case was captured in MARRS# 1711USA004407.; Sender's Comments: US-009507513-1711USA004407:
Chills; Fever; Nausea; Headache; General body pain / Body aches; Extreme tiredness; This is a spontaneous report received from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history, however, the patient had allergies to penicillin, sulfonamide, codeine and clindamycin. The concomitant medications include red yeast rice (MANUFACTURER UNKNOWN), zyrtec (MANUFACTURER UNKNOWN), CoQ10 (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), vitamin E (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) all for an unspecified indication from an unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 04:30, the patient experienced chills, fever, nausea, headache, general body pain (body aches) and extreme tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the reported events. The clinical outcome of the events chills, fever, nausea, headache, general body pain (body aches), extreme tiredness was recovered on an unspecified date.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a consumer refers to her father: a male patient of unknown age. The patient's medical history included shingles. On an unknown date the patient was vaccinated twice with ZOSTAVAX. Concomitant medication was not provided. Since patient received the vaccine, he had continuously gotten shingles. At the time of the report (start date not provided), patient had shingles on his eyes. The outcome of the adverse events was not reported. Additional information is not expected.
Cancer; This spontaneous case was reported by a non-health professional and describes the occurrence of NEOPLASM MALIGNANT (Cancer) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEOPLASM MALIGNANT (Cancer) (seriousness criteria death and medically significant). The reported cause of death was Cancer. It is unknown if an autopsy was performed.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NEOPLASM MALIGNANT (Cancer) to be related.    It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The suspect product dosage text was reported as unknown. No concomitant medication was reported. It was reported that the Moderna Covid-19 caused cancer in 25 patients who were the friends of reporter. The patient will not provide any additional information on these patients. It was also reported that those patients who died were killed by the Moderna Covid-19 vaccine because Moderna vaccine was poison Cancer rates for jabbed Moderna Cancer patients was up 300% The Doctors were part of the Kabal along with Moderna. No treatment medication was reported.  This case contains information about patient 7th out of 25 patients.  Company comment: This is a fatal spontaneous case concerning a patient of unknown gender and age with no medical history reported, who experienced the unexpected serious (death/medically significant) event of neoplasm malignant. The event occurred after a dose of mRNA-1273.222 vaccine. No information disclosed about diagnostic tests performed or treatments received. The benefit-risk relationship of mRNA-1273.222 vaccine is not affected by this report. Events seriousness assessed as reported.     This case was linked to US-MODERNATX, INC.-MOD-2023-735987 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735987:Master case, Patient 1; Reported Cause(s) of Death: Cancer
I came down with myocarditis on May 23, 2021  3months after vaccine Not sure if it is related and doctors aren't sure either but I thought I should report it just in case.
low grade temperature/fever of 99.7 and it fluctuated to 99.3 and 99.2/99.7F, 100.3F then back to 99.2F; Post nasal drip; This is a spontaneous report received from a contactable consumer reported for herself. A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was scheduled to receive her next dose on 11Apr2021. The patient experienced low grade temperature and post nasal drip on unspecified date. Her low grade fever was continuing. The fever started Saturday morning and this was day 3. On Saturday, she woke up and had a fever of 99.7 and it fluctuated to 99.3 and 99.2.  Lab data included body temperature on unspecified dates: 99.7F, 100.3F then back to 99.2F. The outcome of events was unknown.   No follow-up attempts are possible. Information about batch/lot number cannot be obtained.
Pt presented to our office on 12/20 with a rash, fatigue/malaise, and pharyngitis. Rash was raised bumps all over body. Started 3 days after receiving the vaccine with no change as of 12/20. RTC in 2 days for recheck.
Chills, headache, fever, achiness, weakness, congestion, sob, vomiting
Approximately 10 days after the second dose of Pfizer covid-19 vaccine ( 4/20/21) I began experiencing tightness and pain in my chest on the right side. The pain continued and started becoming worse over the next few days and on Monday 4/26/21 I went to have it checked out at an urgent care. Xrays were taken and the physician thought it might be kidney stones so I was sent to emergency room where a right side abdomen CT scan was done. This showed negative for kidney stones so I was sent home. Three days later on Thursday 4/29 21 the pain became extreme so I went to hospital where  I was admitted after testing with pulmonary embolisms and possible pnuemonia.
Started out with discomfort then gold ball size lump.  Progressed to redness, warmth, swelling.  Diagnosed with cellulitis, treating with IV and oral antibiotics.
Beginning 36 hours after the first dose I had a slight fever and felt very achy. However,  At the injection site my arm  became red and swollen itchy and hot to the touch. This began several days after the first dose of the vaccine. It has now been 16 days since the first vaccine and my arm is still red and hot and swollen and itchy. This reds uncomfortable area on my arm has spread into a larger area on my arm and has also grown to include the area higher up in my arm and underneath my arm. I have tried taking an antihistamine and have tried using ice to cool it down to no avail. It seems that it is not improving and has gotten worse. I am scheduled for my second dose of the vaccine on April 14th. My intention is to get it, though I am very worried  about it now.,
Joint inflammation, skin burning, nausea, vomiting, muscle tightness and pain, burning eyes, sinus Inflammation, chest burning, sore throat, fatigue, headache,
Pt was due a DTAP vaccine on 8/2/2014 and TDAP was administered instead.
Irregular and more frequent and heavy periods two weeks after the second (PEDS) pediatric dose of the Pfizer vaccine.
Pneumonia due to flu shots; This case was reported by a consumer via other manufacturer and described the occurrence of pneumonia in a 47-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pneumonia (serious criteria GSK medically significant). On an unknown date, the outcome of the pneumonia was unknown.   The reporter considered the pneumonia to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient had pneumonia due to flu shots.
Initial misuse report received from a healthcare professional on 21 June 2013. It was reported that ACTHIB portion of PENTACEL vaccine was reconstituted with sterile water and administered to a child and DTaP-IPV was not administered. No adverse event was reported. List of documents held by sender: none.
7/14/07 awakened with severe abdominal cramping, nausea,diarrhea, general body aches, headache, rapid heart rate. Went to Urgent Care and was "dismissed as having a virus". Later in the evening with the symptoms "getting worse" went to ER and was again dismissed as "having flu". 7/17/07 headache and neck pain increased and she felt "like my heart was going to pound our of her chest" went to her family physician practice(Family Medicine). She was seen by 3 different physicians over the next several days. Had mosquito bites. One doctor told she "probably had viral meningitis" since it was a possible reaction from MMR.Referred to cardiologist due  heart rate(117 bpm) & arrythmias. Started wearing a heart monitor 7/31/07 to continue for 30 days with daily multiple electronic monitoring by MD. Lost 14 pounds since onset of syx. Given Atavan .5mg (1-2 tabs TID)for anxiety started in the last week. Symptoms improving since then, heart rate still at 117. Beginning to eat, continued diarrhea. Took Imodium AD twice, diarrhea abatted,then recurred. No local reaction at inject site. Cold syx started 8 days into "reaction" , temp highest 99 degrees F.
2ND VACCINE WAS ILL ABOUT 5 - 6 HOURS AFTER - MODERATE ACHES IN JOINTS AND MUSCLES WITH MODERATE HEADACHE. 3RD VACCINE 4 - 5 hrs Bad nausea w headache. Around Wednesday 12:30 - 1:00 am extreme chills, bone joint muscle pain I could hardly walk to urinate lasted til about 8:30 am. Followed by tingling tongue and lips as well as feeling of burning when breathing in like bronchitis. Still had severe nausea and headache. Nothing got rid of headache. Unable to eat until Friday, October 1, 2021. As of today, October 6, 2021, I still have on/off nausea. Foods and drinks don't taste the same. My lips and front of tongue still tingle and there is still burning sensation when breathing.